Article citationsMore>>

Astellas Pharma Europe BV (2014) Vesomni 6 mg/0.4 mg Modified-Release Tablets. Public Assessment Report of the Medicines Evaluation Board in the Netherlands, Solifenacin Succinate/Tamsulosin Hydrochloride, Vesomni SPC, The Netherlands.

has been cited by the following article:

Follow SCIRP
Twitter Facebook Linkedin Weibo
Contact us
WhatsApp +86 18163351462(WhatsApp)
Click here to send a message to me 1655362766
Paper Publishing WeChat
Free SCIRP Newsletters
Copyright © 2006-2022 Scientific Research Publishing Inc. All Rights Reserved.